Achmea Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Achmea Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-407	Closed	-$45K	–	657
2023 Q1	$45K	Hold	407	–	–	﹤0.01%	539
2022 Q4	$43K	Sell	407 -11,945	-97%	-$992K	﹤0.01%	575
2022 Q3	$764K	Hold	12,352	–	–	0.03%	436
2022 Q2	$985K	Hold	12,352	–	–	0.03%	408
2022 Q1	$1.3M	Sell	12,352 -7,346	-37%	-$716K	0.03%	400
2021 Q4	$2.12M	Hold	19,698	–	–	0.1%	184
2021 Q3	$2.16M	Buy	19,698 +407	+2%	+$42.3K	0.07%	331
2021 Q2	$1.81M	Hold	19,291	–	–	0.06%	341
2021 Q1	$1.78M	Hold	19,291	–	–	0.06%	341
2020 Q4	$1.41M	Buy	+19,291	New	+$1.43M	0.05%	360

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Achmea Investment Management's HZNP Position: Q2 2023 in Review

Achmea Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 407 shares — an estimated $45K sold.

Achmea Investment Management first reported a position in HZNP in Q4 2020 and held it in 10 quarters. The position peaked at $2.16M in Q3 2021. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Achmea Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Achmea Investment Management sold 407 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $45K.
Achmea Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 10 quarters.
Achmea Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.16M in Q3 2021.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Achmea Investment Management's 13F filing for Q2 2023, filed 24 Jul 2023.